Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Seastar Medical Hldg Corp (ICU)

Seastar Medical Hldg Corp (ICU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,252
  • Shares Outstanding, K 3,792
  • Annual Sales, $ 140 K
  • Annual Income, $ -24,830 K
  • EBIT $ -14 M
  • EBITDA $ -14 M
  • 60-Month Beta -1.00
  • Price/Sales 3.56
  • Price/Cash Flow N/A
  • Price/Book 0.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.97
  • Number of Estimates 1
  • High Estimate -0.97
  • Low Estimate -0.97
  • Prior Year -9.00
  • Growth Rate Est. (year over year) +89.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.23 +9.42%
on 02/13/26
2.74 -10.95%
on 02/09/26
+0.16 (+7.02%)
since 01/20/26
3-Month
2.20 +10.91%
on 12/24/25
3.90 -37.44%
on 12/08/25
-0.66 (-21.29%)
since 11/20/25
52-Week
2.20 +10.91%
on 12/24/25
25.70 -90.51%
on 03/26/25
-15.86 (-86.67%)
since 02/20/25

Most Recent Stories

More News
SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Strong survival data extending to 90 days Real-world experience shows results consistent with clinical trial data Favorable safety profile – no device-related adverse events DENVER, Feb....

ICU : 2.44 (+1.24%)
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

DENVER, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 2.44 (+1.24%)
SeaStar Medical Announces 2026 Milestones

Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer base Advance SeaStar Medical’s first-in-class SCD therapy for the adult AKI indication –...

ICU : 2.44 (+1.24%)
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

DENVER, Jan. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 2.44 (+1.24%)
SeaStar Medical Announces 1-for-10 Reverse Split

DENVER, Dec. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 2.44 (+1.24%)
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

FDA lowers surveillance requirement to 50 patients from 300 patients in original HDE approval based on assessment of first 21 SAVE Surveillance Registry patients  Compelling efficacy data to date...

ICU : 2.44 (+1.24%)
SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

DENVER, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 2.44 (+1.24%)
SeaStar Medical Announces Appointment of Michael Messinger as CFO

DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 2.44 (+1.24%)
SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Business highlights include: Three new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI) Commercial use of QUELIMMUNE therapy demonstrates...

ICU : 2.44 (+1.24%)
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

DENVER, Nov. 05, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 2.44 (+1.24%)

Business Summary

SeaStar Medical Holding Corporation is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corporation, formerly known as LMF Acquisition Opportunities Inc., is based in Denver, Colorado.

See More

Key Turning Points

3rd Resistance Point 2.60
2nd Resistance Point 2.53
1st Resistance Point 2.49
Last Price 2.44
1st Support Level 2.38
2nd Support Level 2.31
3rd Support Level 2.27

See More

52-Week High 25.70
Fibonacci 61.8% 16.72
Fibonacci 50% 13.95
Fibonacci 38.2% 11.18
Last Price 2.44
52-Week Low 2.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar